IMMUNOLOGIC EVALUATION DURING THE FIRST YEAR OF LIFE OF INFANTS BORN TO CYCLOSPORINE-TREATED FEMALE KIDNEY TRANSPLANT RECIPIENTS

Abstract

continuous exposure to CsA in utero seemingly impairs T-, B-, and NK-cell development and/or maturation, and most of its effects are still apparent at 1 year, which might suggest that conventional vaccinations should be delayed in these infants.